uly 12, 2016—Sirtex Medical Ltd announced the presentation of new data that suggest that patients with liver-dominant metastatic colorectal cancer (mCRC) who underwent first-line treatment with mFOLFOX6 and SIR-Spheres yttrium-90 (Y-90)… Leer noticia completa
